Mint Tower Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,458
Closed -$383K 295
2022
Q4
$383K Sell
1,458
-2,981
-67% -$799K 0.03% 253
2022
Q3
$1M Buy
+4,439
New +$1.08M 0.08% 237
2020
Q2
Sell
-593
Closed -$120K 256
2020
Q1
$120K Buy
+593
New +$130K 0.02% 197
2018
Q2
Sell
-1,950
Closed -$345K 225
2018
Q1
$332K Buy
+1,950
New +$358K 0.04% 123

Other funds holding AMGN

Mint Tower Capital Management's AMGN Position: Q1 2023 in Review

Mint Tower Capital Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 1,458 shares — an estimated $383K sold.

Mint Tower Capital Management first reported a position in AMGN in Q1 2018 and held it in 4 quarters. The position peaked at $1M in Q3 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Mint Tower Capital Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Mint Tower Capital Management sold 1,458 Amgen shares in Q1 2023, an estimated $383K.
  • Mint Tower Capital Management first reported a position in Amgen in Q1 2018 and held it in 4 quarters.
  • Mint Tower Capital Management's Amgen position peaked at $1M in Q3 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.